Clinical Trial Update: A Study Exploring an Induction-Maintenance Kaletra-Based Therapy Versus a Sustiva-Based Regimen in Previously Non-Treated, HIV-1/HCV Co-Infected Subjects [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing Kaletra-based induction/maintenance therapy to a Sustiva-based regimen in previously untreated HIV-1/Hepatitis C co-infected subjects …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Hepatitis C

Drugs mentioned

• Kaletra (lopinavir)
• Sustiva (efavirenz)

Snippet

Sponsor: Abbott | Conditions: HIV Infection, Hepatitis C | Phase 2 | Status: WITHDRAWN